Net Cash Provided by (Used in) Operating Activities |
-659K |
USD |
+18.6% |
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-65.2K |
USD |
+42% |
Q3 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Shares, Issued |
2.54M |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
928K |
USD |
|
Q3 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.07M |
USD |
-60.6% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
7.51M |
USD |
+6.37% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
7.68M |
USD |
+5.71% |
Q2 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
2.86K |
USD |
-50.2% |
Q3 2022 |
Q1 2024 |
Property, Plant and Equipment, Gross |
182K |
USD |
+0.64% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
7.2M |
USD |
+14.5% |
Q2 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2024 |
FY 2024 |
Additional Paid in Capital |
40.3M |
USD |
+2.11% |
Q2 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
152K |
USD |
-18.5% |
Q3 2023 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
281K |
USD |
-16.9% |
Q2 2022 |
FY 2022 |
Share-based Payment Arrangement, Expense |
-150K |
USD |
|
Q4 2022 |
Q2 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
FY 2024 |